Pandemic Darlings The pandemic economy, in original documents
Home Source documents Senate Commerce Committee Statement to Senate, No. 3388 (February 10, 2025)

Senate Commerce Committee Statement to Senate, No. 3388 (February 10, 2025)

Summary

Senate Commerce Committee statement to Senate on Senate Bill No. 3388, dated February 10, 2025, reporting the bill favorably. The bill lets a pharmacist transfer a Schedule II controlled dangerous substance prescription for attention-deficit/hyperactivity disorder to another pharmacist, if the transfer complies with federal regulations. The statement says federal rules recently changed to allow one-time transfers of Schedule II-V prescriptions for the initial filling, and that New Jersey currently allows transfers for Schedule III-V. It says easier transfers help patients when a medicine is in shortage.

Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used

Cite this document

“Senate Commerce Committee Statement to Senate, No. 3388 (February 10, 2025).” Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2025-02-10-scm-s3388-s1-eca116f6b7/, SHA-256 48d28d8e1a97427e8276b6a768b184c1f10187f837dc7a88baf06cdc590fb7e7.

Full text

     SENATE COMMERCE COMMITTEE

                    STATEMENT TO

                  SENATE, No. 3388

 STATE OF NEW JERSEY
                   DATED: FEBRUARY 10, 2025

     The Senate Commerce Committee reports favorably Senate Bill
No. 3388.
    This bill allows pharmacists to transfer Schedule II controlled
dangerous substance prescriptions for attention-deficit/hyperactivity
disorder to other pharmacists.
    Specifically, the bill provides that a Schedule II controlled
dangerous substance that is prescribed for attention-
deficit/hyperactivity disorder may be transferred from a pharmacist
to another pharmacist, provided the prescription transfer is in
compliance with federal regulations.
    Federal rules recently changed to allow the transfer of Schedule
II-V controlled dangerous substance prescriptions between licensed
pharmacies for the initial filling on a one-time basis only, upon
request from the patient. New Jersey currently allows for transfers
of Schedule III-V controlled dangerous substance prescriptions; this
bill would expand allowable transfers to also include Schedule II
controlled dangerous substance prescriptions.
    The bill will allow for greater flexibility for people attempting to
fill attention-deficit/hyperactivity disorder prescriptions.        The
ability to easily transfer prescriptions between pharmacies is
especially valuable to patients who are attempting to fill
prescriptions for medicine that is less available due to a shortage.
Currently, when a patient is unable to fill a prescription at a
particular pharmacy, the patient must ask their health care provider
to send a new prescription to a different pharmacy. The bill will
allow for a more efficient transfer process, by allowing pharmacies
to directly transfer attention-deficit/hyperactivity disorder
prescriptions.

File and source

File
2025-02-10_SCM_S3388_S1.pdf
Size
8,115 bytes
SHA-256
48d28d8e1a97427e8276b6a768b184c1f10187f837dc7a88baf06cdc590fb7e7
Our copy
2025-02-10_SCM_S3388_S1.pdf
Original
No public link identified.
Back to top